Bevacizumab ELISA Kit (DB941018)

Aperçu

Numéro de catalogue	DB941018
Description	Bevacizumab ELISA Kit (DB941018) — Quantitative sandwich ELISA for Bevacizumab. Sample: Plasma, Serum. Range: 312.5 - 20, 000 ng/mL. Sensitivity: 98.1 ng/mL. Highlights ●Sandwich Format — High specificity, reliable quantification. ●High Sensitivity — Optimized for low-abundance target detection. ●Ready-to-Use — Complete kit with pre-coated plates included.
Type d'échantillon	Plasma, Serum
Sensibilité	98.1 ng/mL
Plage	312.5 - 20, 000 ng/mL
Numéro d'accès	P15692
Applications	ELISA
Méthode de détection	Colorimetric
Type de test	Quantitative
Retraitement	80-120%
Expédition	2-8 ℃
Stabilité et stockage	When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃.
Spécifications	Bevacizumab
Noms alternatifs	12-IgG1, F(ab)-12 IgG1, Fab-12 IgG1, rhuMAb-VEGF, ABP 215, 216974-75-3
Contexte	Vascular endothelial growth factor A, long form (Bevacizumab) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. 1. Katsman, M. et al. (2022) Cells 11. PMID: 35455969
Note	For Research Use Only.